Making hay while the Rand shines - OrbVest's latest US investment opportunity
Loading player...
An unexpected weak dollar presents a unique opportunity for South-Africans looking to move funds offshore.
As most of us have been unable to travel abroad, we have not touched our R1m discretionary allowance that amounts to $64,850.84 (R15.42 per $1 at today's exchange rate) to invest offshore.
By putting that R1m, or $64,850.84 at today's exchange rate, into one of our new real estate investment opportunities will earn you an estimated $5,188.07 every year (at 8% cash on cash per annum*), which gets paid to you every quarter and you can re-invest, building compound growth offshore in the worlds default currency.
Alec Hogg from BizNews hosted Martin Freeman and Justin Clarke from ObVest, where they discussed how the latest US election impacts the projects and shared details of OrbVest's latest real estate investment opportunity, Medical 30, located in Phoenix, Arizona.
NOTE: *Past performance is no guarantee of future results. This is subject to certain terms and conditions in respect of some countries and Jurisdictions. In the USA the relevant issuer files under Reg 506(c). OrbVest SA (PTY) LTD is an authorised FSP with License No. 50483. Learn more about your ad choices. Visit megaphone.fm/adchoices
As most of us have been unable to travel abroad, we have not touched our R1m discretionary allowance that amounts to $64,850.84 (R15.42 per $1 at today's exchange rate) to invest offshore.
By putting that R1m, or $64,850.84 at today's exchange rate, into one of our new real estate investment opportunities will earn you an estimated $5,188.07 every year (at 8% cash on cash per annum*), which gets paid to you every quarter and you can re-invest, building compound growth offshore in the worlds default currency.
Alec Hogg from BizNews hosted Martin Freeman and Justin Clarke from ObVest, where they discussed how the latest US election impacts the projects and shared details of OrbVest's latest real estate investment opportunity, Medical 30, located in Phoenix, Arizona.
NOTE: *Past performance is no guarantee of future results. This is subject to certain terms and conditions in respect of some countries and Jurisdictions. In the USA the relevant issuer files under Reg 506(c). OrbVest SA (PTY) LTD is an authorised FSP with License No. 50483. Learn more about your ad choices. Visit megaphone.fm/adchoices
